Investment Summary

Ampersand Capital Partners and The BroadOak Fund Invest In Flagship Biosciences

On September 1, 2022, growth capital firms Ampersand Capital Partners and The BroadOak Fund invested in information technology company Flagship Biosciences

Investment Highlights
  • This is Ampersand Capital Partners’ 2nd and The BroadOak Fund’s 2nd transaction in the Information Technology sector.
  • This is Ampersand Capital Partners’ 63rd and The BroadOak Fund’s 21st transaction in the United States.
  • This is Ampersand Capital Partners’ 2nd and The BroadOak Fund’s 2nd transaction in Colorado.

Investment Summary

Date 2022-09-01
Target Flagship Biosciences
Sector Information Technology
Investor(s) Ampersand Capital Partners
The BroadOak Fund
Deal Type Growth Capital

Target

Flagship Biosciences

Broomfield, Colorado, United States
Flagship Biosciences is a technology-driven tissue analysis services company delivering accurate and informative data available. Flagship Biosciences' services and technology dramatically improve the data and interpretation from traditional pathology methods, eliminating variability associated with typical tissue assessments, and bringing new insights to tissue analysis results. It provides expert scientific consultation for every client. The company's team interprets results, contextualizes tissue biology, and identifies the best course for success. Flagship Biosciences was formed in 2009 and is based in Broomfield, Colorado.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 2

Investor

Ampersand Capital Partners

Wellesley, Massachusetts, United States

Investor Investor Investor Investor Investor


Category Growth Capital Firm
Founded 1988
PE ASSETS 3.0B USD
Size Large
Type Sector Focused
DESCRIPTION

Ampersand Capital Partners is a middle-market private equity group that concentrates on growth equity investment opportunities in the healthcare sector. The Firm looks to invest $10 to $100 million in businesses with $10 to $100 million of revenue. Specific areas of interests within healthcare include lab products, specialty diagnostic equipment, pharmaceutical outsourcing, and specialty pharma. Ampersand generally prefers to be the first and sole institutional investor. Ampersand was formed in 1988 and is based in Wellesley, Massachusetts.


DEAL STATS #
Overall 74 of 84
Sector (Information Technology) 2 of 2
Type (Growth Capital) 23 of 24
State (Colorado) 2 of 2
Country (United States) 63 of 69
Year (2022) 9 of 11
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-08-25 Phosphorex

Hopkinton, Massachusetts, United States

Phosphorex is specializes in long-acting formulations, nanomedicine, and nucleic acid delivery solutions for leading pharmaceutical and biotechnology companies. Phosphorex was founded in 2005 and is based in Hopkinton, Massachusetts.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-09-07 AcuraBio

Darra, Australia

AcuraBio provides recombinant proteins and vaccines, and complex live biotherapeutic products to customers on the leading edge in emerging therapeutics. AcuraBio is based in Darra, Australia.

Buy -
DESCRIPTION

The BroadOak Fund is the investment affiliate of life science focused investment bank BroadOak Capital Partners. The BroadOak Fund provides growth capital to life sciences tools and service providers that have achieved a level of commercial success. The BroadOak Fund is based in Bethesda, Maryland.


DEAL STATS #
Overall 22 of 25
Sector (Information Technology) 2 of 2
Type (Growth Capital) 12 of 14
State (Colorado) 2 of 2
Country (United States) 21 of 23
Year (2022) 6 of 7
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-07-01 Microsize

Quakertown, Pennsylvania, United States

Microsize specializes in particle size reduction, powder classification, and analytical services, catering to a diverse clientele, including small biotechs, big pharma, CDMOs (API, Dosage Form, Integrated), and functional excipient companies. Microsize expertise in milling and micronization processes enables to develop and manufacture products with unique physical property challenges. Microsize was founded in 1994 and is based in Quakertown, Pennsylvania.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-09-28 Emvenio Research

Durham, North Carolina, United States

Emvenio Research is a decentralized research organization (DRO) providing scalable and hybrid decentralized trial solutions with a focus on improving access and health equity in clinical research. Emvenio Research is based in Durham, North Carolina.

Buy -